In case you missed it: July 25 to July 29
A look back at this week's news.
Placental cord drainage may be simpler, more effective than standard practice
Placental cord drainage may be the key to managing the third stage of labor, according to research in BMC Pregnancy and Childbirth.
RVVC treatment drug oteseconazole now commercially available in US
Mycovia Pharmaceuticals recently announced US availability of oteseconazole capsules for the treatment of recurrent vulvovaginal candidiasis in women without reproductive potential.
Fezolinetant making waves for VMS
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
Clinical considerations for monkeypox in pregnancy
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
COVID-19 pregnancy data in the United States: July 25 update
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
ObsEva drops linzagolix, focuses on prospects for preterm labor, IVF
ObsEva plans to drop linzagolix, its leading candidate for the treatment of uterine fibroids, following concerns raised by the FDA.
Low recurrence found after uterine rupture in pregnancy
May 17th 2025A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that while recurrent uterine rupture is rare, patients with a history of rupture face a significantly increased subsequent risk of preterm delivery.
Read More
Self-screening tool for medication abortion found accurate and acceptable
May 17th 2025A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that a self-screening survey with educational videos enables most patients to determine medication abortion eligibility without an ultrasound.
Read More
